Role of serum biomarkers KL-6, SP-D and CCL-18 in assessing interstitial lung disease in systemic sclerosis: A prospective observational study from India.

Lung India · 2026 · PMC13186500 · PMID 42085124

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Serum KL-6 could be a clinically useful biomarker in screening and monitoring CTD-ILD.[ 5 ] Serum levels of CCL-18 and SP-D showed a trend towards negative correlation with FVC, but this was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.